Search

Your search keyword '"Barrett, Kimberly T."' showing total 20 results

Search Constraints

Start Over You searched for: Author "Barrett, Kimberly T." Remove constraint Author: "Barrett, Kimberly T."
20 results on '"Barrett, Kimberly T."'

Search Results

1. The oral nucleoside prodrug GS-5245 is efficacious against SARS-CoV-2 and other endemic, epidemic, and enzootic coronaviruses

2. Oral administration of obeldesivir protects nonhuman primates against Sudan ebolavirus

3. Discovery of GS-5245 (Obeldesivir), an Oral Prodrug of Nucleoside GS-441524 That Exhibits Antiviral Efficacy in SARS-CoV-2-Infected African Green Monkeys

4. Efficacy of the oral nucleoside prodrug GS-5245 (Obeldesivir) against SARS-CoV-2 and coronaviruses with pandemic potential

5. Therapeutic treatment with an oral prodrug of the remdesivir parental nucleoside is protective against SARS-CoV-2 pathogenesis in mice

6. General One-Pot Method for the Preparation of N-tert-Butanesulfinylamine Diastereomer Mixtures as Standards for Stereoselectivity Determinations

7. Spontaneous transfer of chirality in an atropisomerically enriched two-axis system

8. Therapeutic efficacy of an oral nucleoside analog of remdesivir against SARS-CoV-2 pathogenesis in mice

9. Prodrugs of a 1′-CN-4-Aza-7,9-dideazaadenosineC-Nucleoside Leading to the Discovery of Remdesivir (GS-5734) as a Potent Inhibitor of Respiratory Syncytial Virus with Efficacy in the African Green Monkey Model of RSV

10. General one-pot method for the preparation of N-tert-butanesulfinylamine diastereomer mixtures as standards for stereoselectivity determinations

16. Regioselective Derivatizations of a TribrominatedAtropisomeric Benzamide Scaffold.

17. Prodrugs of a 1′-CN-4-Aza-7,9-dideazaadenosine C-Nucleoside Leading to the Discovery of Remdesivir (GS-5734) as a Potent Inhibitor of Respiratory Syncytial Virus with Efficacy in the African Green Monkey Model of RSV

18. Efficacy of the oral nucleoside prodrug GS-5245 (Obeldesivir) against SARS-CoV-2 and coronaviruses with pandemic potential.

19. Therapeutic efficacy of an oral nucleoside analog of remdesivir against SARS-CoV-2 pathogenesis in mice.

Catalog

Books, media, physical & digital resources